Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma ProgressionLucia Casadei, Raphael E. Pollock, Abeba Zewdu et al.|Cancer Research|2017Cited by 199
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J. Bill, Raphael E. Pollock, Jeannine Garnett et al.|Clinical Cancer Research|2015Cited by 106
Targeting the <scp>N</scp>otch pathway: A potential therapeutic approach for desmoid tumorsHui Shang, Raphael E. Pollock, Danielle Braggio et al.|Cancer|2015Cited by 82